FIBRIPHEN 5

Description

Thrombin reagent proposed for the quantitative determination of fibrinogen in human citrated plasma using a clotting method (Clauss method).

Intended use

• Measurement of fibrinogen in plasma.

• Detection of low fibrinogen concentrations.

• Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation

• Risk factor for cardiovascular disease and thrombosis

• Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis).

• Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.